Phoenix Biotech Acquisition Corp. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was USD 0.667736 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | +1.01% | -11.50% | -90.91% |
1st Jan change | Capi. | |
---|---|---|
-90.91% | 14.58M | |
+10.50% | 115B | |
+11.83% | 106B | |
-6.50% | 24.69B | |
-1.51% | 21.97B | |
-5.15% | 19.27B | |
-10.85% | 17.56B | |
-39.36% | 17.32B | |
+5.53% | 14.03B | |
+34.30% | 12.13B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022